| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
DE:RDC
Redcare Pharmacy
|
Jun 18, 2026 | BUY |
Strong Buy
+38.7% avg upside
7 analysts
|
$92.00
38.71% Upside
|
· |
|
DE:TNIE
tonies SE Class A
|
Jun 09, 2026 | BUY |
Strong Buy
+12.3% avg upside
1 analyst
|
$14.50
12.32% Upside
|
· |
|
DE:G24
Scout24
|
Jun 09, 2026 | BUY |
Strong Buy
+15.4% avg upside
19 analysts
|
$100.00
33.06% Upside
|
· |
|
DE:KRN
Krones AG
|
Jun 09, 2026 | BUY |
Hold
-4.5% avg upside
15 analysts
|
$165.00
43.51% Upside
|
· |
|
DE:EVD
CTS Eventim AG & Co. KGaA
|
Jun 09, 2026 | BUY |
Strong Buy
+99.2% avg upside
11 analysts
|
$88.00
68.90% Upside
|
· |
|
DE:DMP
Dermapharm Holding SE
|
May 14, 2026 | BUY |
Buy
+1.0% avg upside
2 analysts
|
$60.00
28.87% Upside
|
· |
|
DE:HYQ
HYPOPORT
|
May 12, 2026 | BUY |
Strong Buy
+249.7% avg upside
6 analysts
|
$190.00
135.69% Upside
|
· |
|
DE:ACT
AlzChem Group AG
|
May 07, 2026 | BUY |
Strong Buy
-2.3% avg upside
5 analysts
|
$197.00
5.88% Upside
|
· |
|
CH:DOCM
DocMorris
|
Mar 23, 2026 | HOLD |
Hold
-1.3% avg upside
8 analysts
|
$4.45
45.47% Downside
|
· |
|
FR:EXA
Exail Technologies
|
Feb 20, 2026 | BUY |
Buy
-25.6% avg upside
2 analysts
|
$150.00
38.46% Upside
|
· |
|
DE:MBB
MBB SE
|
Jan 12, 2026 | HOLD |
Buy
-8.2% avg upside
2 analysts
|
$226.00
26.85% Upside
|
· |
|
DE:ADN1
adesso AG
|
Sep 10, 2025 | BUY |
Strong Buy
+225.6% avg upside
7 analysts
|
$137.00
172.34% Upside
|
· |
|
DE:JST
JOST Werke AG
|
Sep 10, 2025 | BUY |
Strong Buy
+12.1% avg upside
3 analysts
|
$68.00
22.89% Upside
|
· |
|
DE:SBS
STRATEC Biomedical
|
Sep 10, 2025 | BUY |
Strong Buy
+227.8% avg upside
5 analysts
|
$51.00
180.44% Upside
|
· |
|
DE:NB2
Northern Data AG
|
Sep 05, 2025 | BUY |
Buy
+159.8% avg upside
2 analysts
|
$27.00
233.99% Upside
|
· |
|
FR:MF
Wendel SE
|
Jul 21, 2025 | BUY |
Strong Buy
+31.9% avg upside
5 analysts
|
$115.00
37.41% Upside
|
· |
|
DE:BDT
Bertrandt
|
Dec 13, 2024 | HOLD |
Sell
+319.1% avg upside
10 analysts
|
$25.00
168.90% Upside
|
· |
|
DE:DFV
DFV Deutsche Familienversicherung AG
|
Jun 03, 2023 | BUY |
Strong Buy
+84.6% avg upside
1 analyst
|
$14.40
84.61% Upside
|
· |
|
DE:GLJ
GRENKE AG
|
Mar 21, 2023 | BUY |
Strong Buy
+271.0% avg upside
9 analysts
|
$40.00
217.49% Upside
|
· |
|
DE:AR4
AURELIUS Equity Opportunities SE & Co. KGaA
|
Aug 16, 2022 | BUY |
Strong Buy
-89.9% avg upside
2 analysts
|
$45.00
92.08% Downside
|
· |
|
DE:AAG
Aumann AG
|
May 23, 2022 | HOLD |
Hold
+56.3% avg upside
2 analysts
|
$18.00
17.24% Upside
|
· |
|
DE:SHF
SNP Schneider Neureither & Partner AG (Schneider Neureither & Partner AG)
|
Aug 11, 2021 | HOLD |
Hold
-20.2% avg upside
1 analyst
|
$65.00
20.22% Downside
|
· |
|
DE:BFSA
Befesa S.A.
|
Jul 14, 2021 | BUY |
Strong Buy
+51.2% avg upside
7 analysts
|
$78.00
134.52% Upside
|
· |
|
DE:AOF
ATOSS Software
|
Jul 14, 2021 | BUY |
Strong Buy
+105.6% avg upside
4 analysts
|
$220.00
212.01% Upside
|
· |
|
DE:BSL
Basler AG
|
Jul 16, 2020 | BUY |
Strong Buy
+13.2% avg upside
4 analysts
|
$74.00
135.27% Upside
|
· |
|
DE:ED4
EDAG Engineering
|
Nov 20, 2019 | HOLD |
Buy
+282.3% avg upside
4 analysts
|
$12.00
266.95% Upside
|
· |
|
DE:TTK
TAKKT AG
|
Nov 29, 2018 | BUY |
Strong Buy
+633.1% avg upside
7 analysts
|
$22.50
853.33% Upside
|
· |
|
DE:NFN
NFON AG
|
Nov 29, 2018 | BUY |
Hold
+323.9% avg upside
2 analysts
|
$22.00
543.22% Upside
|
· |
|
DE:TPE
PVA TePla
|
Nov 29, 2018 | BUY |
Strong Buy
-23.0% avg upside
5 analysts
|
$15.00
65.56% Downside
|
· |
|
DE:FTK
flatexDEGIRO AG
|
Sep 27, 2018 | BUY |
Strong Buy
+10.3% avg upside
9 analysts
|
$43.00
14.24% Upside
|
· |
|
DE:HOC
HolidayCheck
|
Sep 27, 2018 | BUY |
Strong Buy
+13.8% avg upside
1 analyst
|
$4.80
13.76% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.